https://www.youtube.com/watch?v=IMIYYUJmNNM Patient registries are centralised databases that collect medical information about patients with a particular condition or group of conditions. Patient registries are often particularly valuable for rare diseases, especially international registries as they allow national boundaries to be transcended to capture information about scattered patient populations. This webinar shares... read more →
Jan
24
Dec
08
Dr Femida Gwadry-Sridhar is the Founder and CEO of PulseInfoFrame; a company that builds collaborative communities to enable the best value healthcare and cures for cancer and rare diseases. As founder and CEO of PulseInfoframe, Femida has an extensive background as a pharmacist, epidemiologist and methodologist with over 25 years... read more →
Oct
16
We are excited that Chasing My Cure: A Doctor's Race to Turn Hope Into Action is NOW AVAILABLE everywhere books are sold! The University of Pennsylvania’s Dr. David Fajgenbaum, Pulse Infoframe friend and collaborator and principal investigator of the ACCELERATE registry, wrote Chasing My Cure to share lessons learned about... read more →
Oct
16
In July, Pulse Infoframe CEO Dr. Femida Gwadry-Sridhar chaired the 10th Annual Orphan Drugs & Rare Diseases – West Coast Conference in San Francisco and delivered a keynote talk on the role of real-world evidence and natural history studies in targeting better drug development. In September, Femida participated in the... read more →
Sep
09
We’re excited to share that Dr. David Fajgenbaum, a friend and collaborator of Pulse InfoFrame and PI of the ACCELERATE registry which is powered by Pulse, is sharing his amazing story of discovering a drug to treat his rare disease, which is extending his and other #CastlemanDisease patients’ lives. His book, Chasing My... read more →
Jul
22
Patient-reported data will help inform research in rare form of eye cancer Immunocore Limited, a leading T cell receptor biotechnology company, and Pulse Infoframe, Inc. (Pulse), a data aggregation and analytics company, today announce plans to support the first global patient registry in uveal melanoma (UM), a rare and aggressive... read more →
May
31
Here are a few highlights of our travels from the past few months. Dr. Durhane Wong-Rieger (L), President of the Canadian Organization for Rare Disorders (CORD), and our Dr. Femida Gwadry-Sridhar (R). Pulse Infoframe has just returned from the Great Plains Rare Disease Conference in Sioux Falls, spoken at Patients... read more →
May
30
Several of our clients have celebrated some huge successes this season. Take a look! Simon’s Heart Since 2011, Simon's Heart has advocated for the Sudden Cardiac Arrest Prevention Act. In May, Georgia and West Virginia became the 13th and 14th states, respectively, to pass the Sudden Cardiac Arrest Prevention Act,... read more →
May
30
Our staff has grown in recent months as we help more organizations use real world evidence to find effective treatments for rare diseases. Paul Ferraiolo: Chief Innovation Officer Paul brings over 30 years’ experience to Pulse Infoframe. His previous experience includes Chief Architect of the Oracle Cancer Research Cloud initiative,Chief... read more →
May
30
Our newest customers provide further examples of how real world evidence (RWE) in healthcare is used. Uveal Melanoma Registry This is the first-of-its-kind, global registry to use real RWE in the discovery of new treatments for uveal melanoma, a rare cancer of the eye. This initial rollout is supported by... read more →

